What issues should I pay attention to while taking larotrectinib?

Larotrectinib is a targeted drug used to treat tumors with NTRK gene fusion-positive tumors. This drug has the characteristics of strong selectivity and remarkable efficacy, and is widely used in the treatment of various types of tumors. Because it is a molecularly targeted therapy drug, patients should pay special attention to some important medication precautions during medication, in addition to following the doctor's instructions and taking medication on time, in order to improve the treatment effect and reduce potential adverse reactions. The following are several aspects that patients should pay attention to while taking larotrectinib.
1. Medication compliance and dosage specifications
First of all, larotrectinib should be taken in strict compliance with the dosage and medication time prescribed by the doctor. According to the currently commonly used recommended dosage, adults usually take 100 mg orally twice a day, but the specific dosage may be adjusted based on individual circumstances, liver function status, or adverse drug reactions. Patients should not increase or decrease the dose without authorization or stop taking medication on their own. If you miss a dose, it is recommended to take it as soon as possible; but if it is close to the next dose time, skip the missed dose and should not take a double dose at one time. Regular medication can maintain a stable concentration of the drug in the body, which is a prerequisite for ensuring the therapeutic effect.
2. Be wary of drug interactions

While taking larotrectinib, special attention should be paid to interactions with other medications. Larotinib is mainly metabolized by the hepatic metabolizing enzyme CYP3A4. If strong CYP3A4 inhibitors (such as ketoconazole, clarithromycin) or inducers (such as rifampicin, carbamazepine) are used simultaneously, the efficacy or safety of larotinib may be significantly affected. Therefore, if patients need to use other prescription drugs, over-the-counter drugs, Chinese patent medicines or health care products while taking the medication, they should inform their doctor in advance to avoid adverse drug interactions. In addition, some foods such as grapefruit may also affect CYP3A4 enzyme activity, so it is recommended to avoid eating them while taking medication.

3. Pay attention to common adverse reactions
Although the side effects of larotrectinib are generally mild, some discomfort may still occur during the medication, which requires attention. Common adverse reactions include fatigue, constipation, dizziness, nausea, vomiting, anemia, elevated liver enzymes, etc. In particular, abnormal liver function and neurological-related symptoms (such as dizziness, difficulty concentrating, and ataxia) are common side effects. Patients should undergo regular liver function tests and routine blood tests to detect abnormalities early. If persistent severe discomfort occurs, such as persistent vomiting, high fever, severe headache, blurred vision, etc., you should stop taking the medication immediately and contact your doctor for treatment.
4. Special groups and lifestyle adjustments
For patients with hepatic insufficiency, the dosage should be adjusted appropriately under the guidance of a physician. Larotrectinib is generally not recommended for pregnant and breastfeeding women because of the potential risk to the fetus or baby. During treatment, it is recommended to use effective contraceptive measures to avoid pregnancy. In addition, patients should maintain good living habits, eat reasonably, exercise moderately, and improve their immunity during the medication. Avoid smoking and drinking alcohol, as these behaviors may interfere with drug metabolism and reduce therapeutic efficacy.
In summary, larotinib, as a new type of targeted therapy, has obvious advantages in the treatment of NTRK gene fusion-related tumors. However, in order to maximize its efficacy and reduce adverse reactions, patients must strictly abide by medical instructions, pay attention to drug interactions, regularly monitor physical indicators, and reasonably arrange their living habits during medication. If any abnormal symptoms occur during the treatment, you should seek medical treatment in time to ensure that the treatment cycle is completed safely and effectively.
Reference: https://www.vitrakvi.com/